AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Paratek Pharmaceuticals, Inc. Data, Technology Stack, and Enterprise Applications
AI-Powered Application
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Drift Legacy Drift AI Chatbot Chatbots and Conversational AI AI-Powered Application n/a 2020 2020
In 2020, Paratek Pharmaceuticals, Inc. deployed Drift AI Chatbot on its public website. The deployment implements conversational capabilities categorized under Chatbots and Conversational AI to support on-site customer engagement and digital lead capture. Drift AI Chatbot was configured to run intent-driven conversational workflows, including visitor greeting, qualification question flows, contextual routing, and handoff to human agents or scheduling processes, consistent with typical Chatbots and Conversational AI modules. Configuration emphasizes scripted response libraries, conversational flow orchestration, and ongoing tuning of intent detection and response accuracy within the Drift AI Chatbot platform. Operationally the implementation is embedded in the corporate web channel and supports Paratek Pharmaceuticals, Inc. digital engagement touchpoints, with governance focused on content management, conversation script updates, and platform administration. Integrations reported are limited to website embedding and the Drift administration interface, with monitoring and iterative updates managed through the chatbot platform and web-facing analytics.
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Zoom Video Communications Legacy Zoom Audio Video and Web Conferencing Collaboration n/a 2020 2020
In 2020, Paratek Pharmaceuticals, Inc. deployed Zoom for Audio Video and Web Conferencing to support both internal collaboration and externally facing meeting access. The Zoom application is surfaced on the company website to provide direct external meeting entry points and to schedule virtual engagements with stakeholders. The deployment leverages core Audio Video and Web Conferencing capabilities including video meetings, screen sharing, in-meeting chat, webinar hosting and cloud recording, configured to standard meeting controls and participant management. Zoom is used to run scheduled virtual sessions and ad hoc collaboration, with settings aligned to corporate meeting governance and access controls. Operational coverage focuses on corporate communications and external stakeholder engagement, with the public site integration providing a visible access layer for partners and other external participants. Account provisioning and meeting policy configuration are organized to centralize administration and maintain consistent conferencing controls across the organization.
Collaboration Collaboration 2016 2016
Event Management Collaboration 2022 2022
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
DocuSign Legacy DocuSign eSignature Digital Signing Content Management n/a 2021 2021
In 2021, Paratek Pharmaceuticals, Inc. implemented DocuSign eSignature as a Digital Signing capability on its public website. The deployment embeds DocuSign eSignature to capture legally binding electronic signatures and to surface signing flows directly within web pages. Paratek Pharmaceuticals, Inc. uses DocuSign eSignature as a Digital Signing solution for web-based signature capture and document authentication supporting external contract and consent workflows. The implementation centers on web-embedded signing widgets, server-side document preparation and template-driven workflows, leveraging DocuSign eSignature audit trail and authentication controls as core functional modules. Operational scope is focused on website-driven workflows that connect external signers with internal reviewers, positioning the Digital Signing solution to support sales, legal and partner agreement processes. Governance and control are anchored in platform features such as tamper-evident seals, timestamped audit logs and role-based access to preserve signature integrity for documents submitted via the website.
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
CRM CRM 2021 2021
Customer Experience CRM 2018 2018
Sales Automation, CRM, Sales Engagement CRM 2021 2021
ITSM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
IT Service Management ITSM 2019 2019
Remote Monitoring and Management ITSM 2021 2021
PaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Transactional Email PaaS 2021 2021
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2016 2016
Application Hosting and Computing Services IaaS 2022 2022
Application Hosting and Computing Services IaaS 2016 2016
Content Delivery Network IaaS 2020 2020
Content Delivery Network IaaS 2020 2020
Content Delivery Network IaaS 2020 2020
IT Decision Makers and Key Stakeholders at Paratek Pharmaceuticals, Inc.
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Paratek Pharmaceuticals, Inc. Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Paratek Pharmaceuticals, Inc. Technographics

Paratek Pharmaceuticals, Inc. is a Life Sciences organization based in United States, with around 207 employees and annual revenues of $120.0 million.

Paratek Pharmaceuticals, Inc. operates a diverse technology stack with applications such as Drift AI Chatbot, Zoom and DocuSign eSignature, covering areas like Chatbots and Conversational AI, Audio Video and Web Conferencing and Digital Signing.

Paratek Pharmaceuticals, Inc. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Drift, Zoom Video Communications and DocuSign.

Paratek Pharmaceuticals, Inc. recently adopted applications including Capture Virtual Journey in 2022, Amazon EC2 in 2022 and DocuSign eSignature in 2021, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Paratek Pharmaceuticals, Inc.’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Paratek Pharmaceuticals, Inc.’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Paratek Pharmaceuticals, Inc. technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.